Literature DB >> 3293826

Development of recommendations for the protection of short-stay travellers to malaria endemic areas: Memorandum from two WHO Meetings.

.   

Abstract

In the past, since malaria chemoprophylaxis was assumed to be of benefit and with no serious complications, it was recommended to all travellers who were at risk of acquiring the disease. The current epidemiological situation of malaria is marked by the increasing spread of Plasmodium falciparum resistance to chloroquine and by problems due to the toxicity of other drugs. Recommendations for malaria prophylaxis should therefore be based on an epidemiological approach which takes into account the risk of acquiring the infection, the toxicity and effectiveness of the available antimalarial drugs, the traveller's perception of these risks, and the human factors that influence the use of all possible protective measures against malaria.This Memorandum describes the epidemiological approach and the data bases required for the development of recommendations on prophylaxis for short-stay visitors in malaria endemic areas, and gives guidelines on the protective measures and drugs that may be used in defined situations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3293826      PMCID: PMC2491041     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  23 in total

1.  A multi-centre trial of alpha-6-desoxy-5-oxytetracycline (doxycycline).

Authors:  M Serembe
Journal:  Chemotherapy       Date:  1975       Impact factor: 2.544

2.  Kinetic studies of mefloquine and of one of its metabolites, Ro 21-5104, in the dog and in man.

Authors:  D E Schwartz; W Weber; D Richard-Lenoble; M Gentilini
Journal:  Acta Trop       Date:  1980-09       Impact factor: 3.112

3.  Fatal malaria in US civilians.

Authors:  H O Lobel; C C Campbell; J M Roberts
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

4.  Does chloroquine contribute to the risk of serious adverse reactions to fansidar?

Authors:  L Rombo; J Stenbeck; H O Lobel; C C Campbell; M Papaioanou; K D Miller
Journal:  Lancet       Date:  1985-12-07       Impact factor: 79.321

5.  Analysis of filter-paper-absorbed, finger-stick blood samples for chloroquine and its major metabolite using high-performance liquid chromatography with fluorescence detection.

Authors:  L C Patchen; D L Mount; I K Schwartz; F C Churchill
Journal:  J Chromatogr       Date:  1983-11-11

6.  Identification of adverse reactions to new drugs. IV--Verification of suspected adverse reactions.

Authors:  G R Venning
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-12

7.  Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems.

Authors:  G R Venning
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05

8.  Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting.

Authors:  E Weidekamm; H Plozza-Nottebrock; I Forgo; U C Dubach
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

9.  Plasmodium falciparum resistance to pyrimethamine and chlorproguanil -- host or parasite dependent?

Authors:  A Björkman; J Brohult; V Sirleaf; M Willcox; E Bengtsson
Journal:  Ann Trop Med Parasitol       Date:  1980-04

10.  Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria.

Authors:  C S Hatton; T E Peto; C Bunch; G Pasvol; S J Russell; C R Singer; G Edwards; P Winstanley
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

View more
  6 in total

Review 1.  Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria.

Authors:  H Bukirwa; J Critchley
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

Review 2.  Prevention of malaria.

Authors:  J S Keystone
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

3.  Behavioural aspects of travellers in their use of malaria presumptive treatment.

Authors:  P Schlagenhauf; R Steffen; A Tschopp; P Van Damme; M L Mittelholzer; H Leuenberger; C Reinke
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

4.  High-resolution melting PCR assay, applicable for diagnostics and screening studies, allowing detection and differentiation of several Babesia spp. infecting humans and animals.

Authors:  Wioletta Rozej-Bielicka; Aleksander Masny; Elzbieta Golab
Journal:  Parasitol Res       Date:  2017-08-10       Impact factor: 2.289

5.  Malaria risk in travelers.

Authors:  Helena Hervius Askling; Jenny Nilsson; Anders Tegnell; Ragnhild Janzon; Karl Ekdahl
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

6.  Stand-by emergency treatment (SBET) of malaria in Spanish travellers: a cohort study.

Authors:  Pietro Ferrara; Cristina Masuet-Aumatell; Fernando Agüero; Josep Maria Ramon-Torrell
Journal:  Malar J       Date:  2018-04-02       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.